Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.5 (EPT/RI) - WS Atkins Plc Amendment

1 Jun 2017 18:00

RNS Number : 9335G
JPMorgan Securities Plc
01 June 2017
Β 

AMENDMENT

INCREASED EQUITY PURCHASES BY 4,542 TO 162,371

ADDED EQUITY SWAP SALES OF 4,542

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-

SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

WS Atkins Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Financial Adviser & Corporate Broker to WS Atkins Plc

(d) Date dealing undertaken:

30 May 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

(GBP)

Β 

Lowest price per unit paid/received

(GBP)

Β 

Ordinary Shares

Β 

Purchases

Β 

Sales

162,371

Β 

16,265

20.8788

Β 

20.8800

20.8100

Β 

20.8000

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

Ordinary Shares

Equity Swaps

Β 

Β 

Long

Β 

Β 

Short

64

268

Β 

3,298

12,000

511

20

4,542

40,000

1,620

20.8084

20.8184

Β 

20.8116

20.8153

20.8175

20.8320

20.8412

20.8452

20.8788

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBP)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(GBP)

Ordinary Shares

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(GBP)

Ordinary Shares

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) (GBP)

Β 

Β 

Β 

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

Β 

Β 

Date of disclosure:

01 June 2017

Contact name:

Tung Le

Telephone number:

020 7742 7272

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEREAXKFEEEXEFF
Date   Source Headline
2nd Jul 20125:23 pmRNSDirector/PDMR Shareholding
29th Jun 20124:17 pmRNSAnnual Financial Report
26th Jun 20124:45 pmRNSDirector/PDMR Shareholding
25th Jun 20125:02 pmRNSDirector/PDMR Shareholding
21st Jun 20123:02 pmRNSHolding(s) in Company
20th Jun 20124:23 pmRNSDirector/PDMR Shareholding
20th Jun 20124:11 pmRNSDirector/PDMR Shareholding
19th Jun 20123:24 pmRNSDirector/PDMR Shareholding
18th Jun 20124:02 pmRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSFinal Results
16th May 20124:16 pmRNSDirector/PDMR Shareholding
14th May 20127:00 amRNS$75m US private placement
8th May 20127:00 amRNSAtkins completes sale of PFI investment
25th Apr 20124:25 pmRNSHolding(s) in Company
17th Apr 20124:05 pmRNSDirector/PDMR Shareholding
11th Apr 20127:00 amRNSTrading Statement
3rd Apr 20123:10 pmRNSDirector/PDMR Shareholding
16th Mar 20122:24 pmRNSDirector/PDMR Shareholding
15th Mar 20124:24 pmRNSDirector/PDMR Shareholding
1st Mar 20123:21 pmRNSDirector/PDMR Shareholding
27th Feb 20124:16 pmRNSAtkins appointed on strategic roads contract
21st Feb 20127:00 amRNSAnalyst Presentation
17th Feb 20122:00 pmRNSAtkins and Assystem expand their alliance
16th Feb 20125:43 pmRNSDirector/PDMR Shareholding
15th Feb 201212:49 pmRNSDirector/PDMR Shareholding
9th Feb 20127:00 amRNSInterim Management Statement
31st Jan 20122:37 pmRNSDirector/PDMR Shareholding
27th Jan 20122:45 pmRNSDirector/PDMR Shareholding
18th Jan 20125:11 pmRNSHolding(s) in Company
17th Jan 20122:04 pmRNSDirector/PDMR Shareholding
13th Jan 20127:00 amRNSSignalling renewal framework contracts
10th Jan 20127:00 amRNSQatar transport infrastructure contract
16th Dec 20113:42 pmRNSDirector/PDMR Shareholding
1st Dec 20113:06 pmRNSAtkins completes sale of Asset Management business
28th Nov 201110:30 amRNSAtkins awarded Qatar engineering contract
23rd Nov 20113:59 pmRNSDirector/PDMR Shareholding
17th Nov 20117:00 amRNSHalf Yearly Report
16th Nov 20113:14 pmRNSDirector/PDMR Shareholding
19th Oct 201111:21 amRNSDirector/PDMR Shareholding
10th Oct 20112:37 pmRNSDirector/PDMR Shareholding
7th Oct 201111:39 amRNSHolding(s) in Company
5th Oct 201111:00 amRNSDisposal
4th Oct 20113:57 pmRNSDirector/PDMR Shareholding
4th Oct 20113:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20117:00 amRNSAnalyst Presentation
30th Sep 20113:00 pmRNSBoard Composition
30th Sep 201112:25 pmRNSDirector/PDMR Shareholding
29th Sep 201110:33 amRNSDirector/PDMR Shareholding
27th Sep 20119:13 amRNSDirector/PDMR Shareholding
26th Sep 20114:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.